Pharming Completes Cash Offer For Abliva, Extends Acceptance
07 Feb 2025 //
GLOBENEWSWIRE
Pharming pays $66M to for Abliva, mitochondrial disease med
16 Dec 2024 //
FIERCE PHARMA
Pharming Announces Cash Offer for Abliva AB Shareholders
15 Dec 2024 //
GLOBENEWSWIRE
Abliva Reports Positive Interim Analysis Of KL1333 FALCON Study
18 Jul 2024 //
GLOBENEWSWIRE
Abliva To Host KOL Event On KL1333 In Primary Mitochondrial Disease
13 May 2024 //
GLOBENEWSWIRE
Owl, Abliva Partner on Traumatic Brain Injury Drug
20 Nov 2023 //
CONTRACT PHARMA
Owl Therapeutics Enters a Strategic Clinical Collaboration With Abliva
17 Nov 2023 //
PR NEWSWIRE